Economic analysis of osimertinib in previously untreated EGFR-mutant advanced non-small cell lung cancer in Canada von Ezeife, Doreen A., Kirk, Veronica, Chew, Derek S., Nixon, Nancy A., Lee, Roy, Le, Lisa W., Chan, Kelvin K.-W., Leighl, Natasha B.

Volltext

Impact of Oncology Drug Review Times on Public Funding Recommendations von Hussain, Marya, Wong, Chelsea, Taguedong, Eddy, Verma, Saurav, Mahsin, Md, Karim, Safiya, Lee-Ying, Richard, Ezeife, Doreen A

Volltext

Reflex ROS1 IHC Screening with FISH Confirmation for Advanced Non-Small Cell Lung Cancer-A Cost-Efficient Strategy in a Public Healthcare System von Makarem, Maisam, Ezeife, Doreen A, Smith, Adam C, Li, Janice J N, Law, Jennifer H, Tsao, Ming-Sound, Leighl, Natasha B

Volltext

The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer von Ezeife, Doreen A., Spackman, Eldon, Juergens, Rosalyn A., Laskin, Janessa J., Agulnik, Jason S., Hao, Desiree, Laurie, Scott A., Law, Jennifer H., Le, Lisa W., Kiedrowski, Lesli A., Melosky, Barbara, Shepherd, Frances A., Cohen, Victor, Wheatley-Price, Paul, Vandermeer, Rachel, Li, Janice J., Fernandes, Roxanne, Shokoohi, Aria, Lanman, Richard B., Leighl, Natasha B.

Volltext

Ensuring equitable access to cancer care for Black patients in Canada von Ezeife, Doreen A, Padmore, Greg, Vaska, Marcus, Truong, Tony H

Volltext

Un accès équitable aux soins contre le cancer pour les personnes noires au Canada von Ezeife, Doreen A., Padmore, Greg, Vaska, Marcus, Truong, Tony H.

Volltext

Value assessment of oncology drugs using a weighted criterion‐based approach von Ezeife, Doreen A., Dionne, Francois, Fares, Aline Fusco, Cusano, Ellen Laura Rose, Fazelzad, Rouhi, Ng, Wenzie, Husereau, Don, Ali, Farzad, Sit, Christina, Stein, Barry, Law, Jennifer H., Le, Lisa, Ellis, Peter Michael, Berry, Scott, Peacock, Stuart, Mitton, Craig, Earle, Craig C., Chan, Kelvin K. W., Leighl, Natasha B.

Volltext

Financial Burden Among Patients With Lung Cancer in a Publically Funded Health Care System von Ezeife, Doreen A., Morganstein, Brandon Josh, Lau, Sally, Law, Jennifer H., Le, Lisa W., Bredle, Jason, Cella, David, Doherty, Mark K., Bradbury, Penelope, Liu, Geoffrey, Sacher, Adrian, Shepherd, Frances A., Leighl, Natasha B.

Volltext

Un acces equitable aux soins contre le cancer pour les personnes noires au Canada von Ezeife, Doreen A, Padmore, Greg, Vaska, Marcus, Truong, Tony H

Volltext

An Arm and a Leg: The Rising Cost of Cancer Drugs and Impact on Access von Leighl, Natasha B, Nirmalakumar, Sharon, Ezeife, Doreen A, Gyawali, Bishal

Volltext

Comparison of oncology drug approval between Health Canada and the US Food and Drug Administration von Ezeife, Doreen A., Truong, Tony H., Heng, Daniel Y. C., Bourque, Sylvie, Welch, Stephen A., Tang, Patricia A.

Volltext

Reply to discrepancies in drug approvals: A global dilemma von Ezeife, Doreen A., Truong, Tony H., Tang, Patricia A.

Volltext

Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC von Planchard, David, Jänne, Pasi A, Cheng, Ying, Yang, James C-H, Yanagitani, Noriko, Kim, Sang-We, Sugawara, Shunichi, Yu, Yan, Fan, Yun, Geater, Sarayut L, Laktionov, Konstantin, Lee, Chee K, Valdiviezo, Natalia, Ahmed, Samreen, Maurel, Jean-Marc, Andrasina, Igor, Goldman, Jonathan, Ghiorghiu, Dana, Rukazenkov, Yuri, Todd, Alex, Kobayashi, Kunihiko

Volltext

Abstract A26: Defining VALUE: Routine liquid biopsy in NSCLC diagnosis—a Canadian trial in progress von Agulnik, Jason, Law, Jennifer H., Juergens, Rosalyn, Laskin, Janessa, Laurie, Scott, Hao, Desiree, Ezeife, Doreen A., Le, Lisa W., Kiedrowski, Lesli A., Lanman, Richard B., Leighl, Natasha B.

Volltext

Abstracts of the 2022 Canadian Association of Medical Oncologists Annual Scientific Meeting von Ezeife, Doreen, Aseyev, Olexiy, Gill, Sharlene, Welch, Stephen, Colwell, Bruce, Hao, Desiree

Volltext

Association between oncology drug review times and public funding recommendations von Gagnon, Richard, Wong, Chelsea, Taguedong, Eddy, Maneesh, Parthiv, Karim, Safiya, Lee-Ying, Richard M., Ezeife, Doreen Anuli

Volltext

The association between neighborhood‐level income and cancer stage at diagnosis and survival in Alberta von Ruan, Yibing, Heer, Emily, Warkentin, Matthew T., Jarada, Tamer N., O’Sullivan, Dylan E., Hao, Desiree, Ezeife, Doreen, Cheung, Winson, Brenner, Darren R.

Volltext

Do the American Society of Clinical Oncology Value Framework and the European Society of Medical Oncology Magnitude of Clinical Benefit Scale Measure the Same Construct of Clinical... von Cheng, Sierra, McDonald, Erica J, Cheung, Matthew C, Arciero, Vanessa S, Qureshi, Mahin, Jiang, Di, Ezeife, Doreen, Sabharwal, Mona, Chambers, Alexandra, Han, Dolly, Leighl, Natasha, Sabarre, Kelley-Anne, Chan, Kelvin K W

Volltext

Impact of Value Frameworks on the Magnitude of Clinical Benefit: Evaluating a Decade of Randomized Trials for Systemic Therapy in Solid Malignancies von Cusano, Ellen, Wong, Chelsea, Taguedong, Eddy, Vaska, Marcus, Abedin, Tasnima, Nixon, Nancy, Karim, Safiya, Tang, Patricia, Heng, Daniel Y C, Ezeife, Doreen

Volltext

Impact of value frameworks on the magnitude of clinical benefit: Evaluating a decade of randomized trials for systemic therapy in solid malignancies von Cusano, Ellen, Wong, Chelsea, Vaska, Marcus, Nixon, Nancy Alice, Karim, Safiya, Abedin, Tasnima, Tang, Patricia A., Heng, Daniel Yick Chin, Ezeife, Doreen Anuli

Volltext